New tool aims to capture daily life with rare inflammatory diseases
NCT ID NCT03569644
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study involved 39 adults and children with autoinflammatory diseases like FMF and Still's disease. Researchers conducted interviews to understand how these conditions affect quality of life. The goal was to create a tool that doctors can use to better assess and address patients' needs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CH André Mignot
Le Chesnay, France, 78150, France
-
Dr Maryam PIRAM
Le Kremlin-Bicêtre, 94270, France
-
TENON
Paris, Paris, 75020, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could the gut hold the key to calming autoinflammatory Flare-Ups?
- New drug combo aims to tame rare inflammatory disease
- Can a quick quiz replace gym tests for kids with chronic illness?
- New study tracks ilaris use in rare inflammatory diseases across europe
- Skin glow may predict inflammation in FMF patients
- Scientists hunt for genetic clues in rare childhood immune disorders